Heart Disease News and Research

Latest Heart Disease News and Research

3M introduces Littmann electronic stethoscope with Bluetooth

Taking the stethoscope into the 21st century, 3M today announced the introduction of the 3M™ Littmann® Electronic Stethoscope Model 3200, a next-generation auscultation device featuring Bluetooth technology that wirelessly transfers heart, lung and other body sounds to software for further analysis.

19 Aug 2009

Newly discovered anti-aging gene linked to high blood pressure

Researchers at the University of Oklahoma Health Sciences Center have shown the first link between a newly discovered anti-aging gene and high blood pressure. The results, which appear this month in the journal Hypertension, offer new clues on how we age and how we might live longer.

19 Aug 2009

Health Research International publishes reports on opportunities presented by transcatheter and minimally invasive surgical valve technologies

Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine and drive a multi-billion dollar market. However, questions remain about the timing of adoption of these new technologies, the numbers and types of patients ultimately benefitting from them, the impact of reimbursement, and where transcatheter technologies pose the greatest threat to the current surgical caseload, especially in light of developments in minimally invasive heart valve surgery technologies.

19 Aug 2009

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Children with clinically suspected pulmonary embolism (PE) are increasingly being evaluated with CT angiography (CTA). Even though many children ultimately test negative for PE, study results suggest that CTA is still valuable for this indication because it has the ability to accurately detect a variety of alternative diagnoses.

19 Aug 2009

Medicare picks twelve New Jersey hospitals to test incentive system

Twelve New Jersey hospitals and their participating physicians have received approval from the federal government to test an innovative new incentive method that aims to reduce healthcare costs while improving quality of care.

19 Aug 2009

Arzoxifene phase 3 study results reported by Lilly

Eli Lilly and Company announced today that initial results from its pivotal, five-year, Phase III GJAD "GENERATIONS" trial for arzoxifene met its primary endpoints of significantly reducing the risk of vertebral fracture and invasive breast cancer in postmenopausal women.

19 Aug 2009

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

19 Aug 2009

Compete rates Healthgrades.com number one doctor-ratings web site

HealthGrades.com is the #1 doctor-ratings Web site – by an enormous margin – according to an analysis of Web traffic by Compete, a TNS Media company. HealthGrades.com, long known for its hospital-quality ratings, is the public Web site of the leading healthcare ratings company, featuring quality reports and ratings of every practicing doctor, hospital and nursing home in the country.

19 Aug 2009

New understanding on meningitis cause

A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. The new finding, which may guide development of improved vaccines to protect those most vulnerable, including young infants and the elderly, is now available online in the Journal of Experimental Medicine.

19 Aug 2009

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

19 Aug 2009

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

GfK Healthcare, the largest provider of fully integrated custom health care marketing research in the United States, announced today the launch of Brand BEAT™ (Brand Equity Assessment & Tracking), a complete package of health care-specific brand positioning diagnostic tools for measuring the cognitive and emotional strengths of a brand.

19 Aug 2009

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.

19 Aug 2009

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections.

19 Aug 2009

FDA places Geron Corporation's IND for spinal cord injury on clinical hold

Geron Corporation (Nasdaq:GERN) today announced that its IND (Investigational New Drug application) for GRNOPC1, a cell therapy for neurologically complete, subacute spinal cord injury, has been placed on clinical hold by the FDA pending the agency’s review of new nonclinical animal study data submitted by the company. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.

19 Aug 2009

Study shows lower short-term mortality rates in patients hospitalized for AMI

From 1995 to 2006, hospital 30-day death rates decreased significantly for Medicare patients hospitalized for a heart attack, as did the variation in the rate between hospitals, according to a study in the August 19 issue of JAMA.

19 Aug 2009

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Seattle-based, women-owned, Beveragette Ventures LLC, developers of the innovative, wellness beverage line, GEM, announced today the launch of Keep it Cool(TM), an all-natural, low-calorie, peach-pineapple flavored beverage, with clinically proven ingredients to minimize the many symptoms of menopause; hot flashes, night sweats, mood swings, irritability and sleeplessness.

19 Aug 2009

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New Drug application (IND) of AM461, its internally-discovered, oral drug candidate for the treatment and control of inflammatory and allergic disease linked to the arachidonic acid pathway, to the U.S. Food and Drug Administration.

19 Aug 2009

American Asthma Foundation awards $750,000 to Dr.Charles Zuker

Dr. Charles Zuker, a renowned expert on the nerves that determine taste and smell, has been awarded $750,000 by the American Asthma Foundation (AAF). Dr. Zuker will apply his expertise to asthma by defining the nerves that contract the airways during an asthma attack in order to reduce the severity of these episodes.

19 Aug 2009

Heart Disease News and Research

Latest Heart Disease News and Research

3M introduces Littmann electronic stethoscope with Bluetooth

Newly discovered anti-aging gene linked to high blood pressure

Health Research International publishes reports on opportunities presented by transcatheter and minimally invasive surgical valve technologies

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Researchers find connection between eye disease and arginase

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Medicare picks twelve New Jersey hospitals to test incentive system

Arzoxifene phase 3 study results reported by Lilly

Bioheart's executive management team strengthened by the inclusion of board members

Compete rates Healthgrades.com number one doctor-ratings web site

New understanding on meningitis cause

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

FDA places Geron Corporation's IND for spinal cord injury on clinical hold

Study shows lower short-term mortality rates in patients hospitalized for AMI

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

American Asthma Foundation awards $750,000 to Dr.Charles Zuker

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Heart Disease News and Research

Latest Heart Disease News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in